This paper uses an endogenous growth model to examine the interaction between trade, economic growth, and the environment. We find that whether trade enhances or retards growth depends on the relation between factor intensities of exportable, importable, and R&D and the relative abundance of the...

An R&D based endogenous growth - applied general equilibrium model is developed from an underlying analytical model which combines Romer's capital variety with Grossman and Helpman's multi-sector open economy model. The transitional dynamics of the analytical model are derived. For numerical...

The implications of environmental externalities are studied within three classes of endogenous growth models viz. the linear technology models, the human capital models, and the R&D and innovation models. The long-run rate of economic growth changes when environmental extemalities are introduced;...

The global burden of disease (GBD) was measured using a new indicator called disability-adjusted life years (DALYs). The formula to calculate DALYs is based on the idea of time being a continuous variable, which is not consistent with the way economic and health data are collected and reported,...

This study investigated inequalities in physically healthy days in the United States during 1993-1999, by socioeconomic and demographic group. The generalized entropy GE(2) and other indices were computed using data from the Behavioral Risk Factor Surveillance System survey, 1993-1999. The...

The availability of patient-level data from clinical trials has spurred a lot of interest in developing methods for quantifying and presenting uncertainty in cost-effectiveness analysis (CEA). Although the majority has focused on developing methods for using sample data to estimate a confidence...

We consider assumptions about preferences implicit in the person trade-off exercises used to derive health-related quality of life measures for the Global and US Burden of Disease Projects. Because these methods and their results have the potential of being adopted by other researchers, a...

Widespread use of antibiotics is considered the major driving force behind the development of antibiotic resistance. The benefits of exceeding the welfare-maximizing level of antibiotic use are below the costs of resistance created by this excess quantity of antibiotics used, thereby resulting...